Valuation: Progyny, Inc.

Market Cap 2.13B 1.91B 1.76B 1.6B 2.99B 203B 3.02B 21.09B 8.4B 106B 7.98B 7.81B 337B P/E 2026 *
21.7x
P/E 2027 * 18.5x
Enterprise Value 1.96B 1.76B 1.63B 1.47B 2.75B 187B 2.78B 19.43B 7.74B 97.64B 7.35B 7.2B 310B EV / Sales 2026 *
1.43x
EV / Sales 2027 * 1.17x
Free-Float
75.41%
Yield 2026 *
-
Yield 2027 * -
1 day+0.54%
1 week-2.00%
Current month+10.64%
1 month+9.21%
3 months-9.40%
6 months+51.63%
Current year+8.53%
1 week 27.55
Extreme 27.55
29.25
1 month 24.79
Extreme 24.79
29.25
Current year 16.1
Extreme 16.1
33.06
1 year 16.1
Extreme 16.1
33.06
3 years 13.39
Extreme 13.39
42.08
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2022
Director of Finance/CFO 60 15/09/2020
Chief Operating Officer 56 17/04/2025
Director TitleAgeSince
Chairman 66 01/01/2022
Director/Board Member 77 16/12/2016
Director/Board Member 58 01/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
14/10/26 Tax

Chief Operating Officer

-3,438 0.0045%
23/09/26 Sell

General Counsel

-3,903 0.0051%
17/09/26 Tax

Executive/Senior Manager

-819 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%-2.00%+44.93%-8.59% 2.13B
-0.80%-2.37%+10.67%-22.41% 368B
-1.68%-4.54%+22.10%-6.13% 91.07B
-1.10%-3.08%-4.35%-2.72% 78.82B
-0.72%-3.19%+39.71%-19.27% 49.82B
-2.42%-4.54%+102.02%-0.64% 34.02B
-0.68%-7.82%+21.65%-41.06% 10.39B
+6.72%-4.15%+14.31%+42.25% 8.09B
+3.46%+0.21%+27.39%+425.16% 2.46B
+1.61%-3.08%-54.66%+19.59% 1.67B
Average +0.62%-4.18%+22.38%+38.62% 64.68B
Weighted average by Cap. -0.82%-2.77%+17.72%-13.96%

Financials

2026 *2027 *
Net sales 1.37B 1.23B 1.14B 1.03B 1.93B 131B 1.95B 13.63B 5.43B 68.49B 5.16B 5.05B 217B 1.51B 1.36B 1.26B 1.14B 2.12B 144B 2.15B 15.01B 5.98B 75.45B 5.68B 5.56B 240B
Net income 107M 95.7M 88.47M 80.13M 150M 10.16B 152M 1.06B 421M 5.32B 400M 392M 16.88B 125M 112M 104M 93.88M 175M 11.9B 178M 1.24B 494M 6.23B 469M 459M 19.77B
Net Debt -168M -150M -139M -126M -235M -15.97B -238M -1.66B -662M -8.36B -629M -616M -26.52B -358M -321M -297M -269M -502M -34.09B -508M -3.55B -1.41B -17.84B -1.34B -1.31B -56.63B
Projected Income Statement - Annual - Progyny, Inc.
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
28/10/26 $27.87 +0.54% 543,187
27/10/26 $27.72 -1.46% 923,761
26/10/26 $28.13 -2.90% 650,928
23/10/26 $28.97 -0.52% 565,859
22/10/26 $29.12 +2.39% 744,612
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Progyny, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
27.88USD
Average target price
34.42USD
Spread / Average Target
+23.45%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Progyny, Inc.
  1. Stock Market
  2. Stocks
  3. PGNY Stock